Bernard Rachet

16PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)MortalityHaematologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 16, 2026
How equity in cancer services has been defined and measured, and why it matters: a scoping review of Universal Health Coverage systems.

|Jun 11, 2026
Surgery or radiotherapy for early-stage cancer study protocol for an emulated target trial of radical radiotherapy versus radical cystectomy, with either following neoadjuvant chemotherapy, for organ-confined muscle-invasive bladder cancer.

|Jul 14, 2025
Surgery or radiotherapy for early-stage cancer study (SORT) target trial protocol: stereotactic ablative radiotherapy (SABR) with curative intent versus surgical resection for early-stage non-small cell lung cancer (NSCLC).

Eva Kagenaar, David G Lugo-Palacios, Andrew Hutchings

|Feb 20, 2025
Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015-2021 cohort study.

Ananya Malhotra, Erick Suazo-Zepeda, Petra C Vinke

|Feb 11, 2023
Is the Social Gradient in Net Survival Observed in France the Result of Inequalities in Cancer-Specific Mortality or Inequalities in General Mortality?

Laure Tron, Laurent Remontet, Mathieu Fauvernier

|Jan 30, 2023
Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population-based study in France.

Kueshivi Midodji Atsou, Bernard Rachet, Edouard Cornet

Pageof 3

Frequent Collaborators

3 joint publications

Miguel Angel Luque-Fernandez

2 joint publications

Richard Grieve

2 joint publications

Laurent Remontet

2 joint publications

Aurélien Belot